Table 3.
Immunosuppression and adjunctive treatment
Variable | High-dose prednisone n = 39 |
First-line CNI n = 11 |
Rescue CNI n = 16 |
P value |
---|---|---|---|---|
Prednisone | ||||
Months on prednisone | 13 (7–22) | 8 (6–12) | 24 (12–28) | <0.001 |
Cumulative prednisone, g | 9.3 (7.5–12.5) | 2.5 (1.8–3.1) | 13.8 (9.2–15.8) | <0.001 |
Cumulative prednisone, mg/kg | 134 (112–180) | 36 (26–39) | 177 (145–209) | <0.001 |
Months to taper <10 mg | 7 (6–12) | 6 (4–7) | 11 (6–18) | 0.003 |
Calcineurin inhibitor | ||||
Tacrolimus | — | 5 (45.5) | 8 (50.0) | 0.816 |
Avg plasma level, ng/dl | — | 5.2 (4.0–7.9) | 5.8 (4.4–7.3) | 0.698 |
Cyclosporine | — | 6 (54.5) | 8 (50.0) | 0.816 |
Avg plasma level, ng/dl | — | 134 (92–186) | 128 (92–172) | 0.771 |
Months on CNI | — | 12 (6–16) | 16 (9–25) | 0.174 |
Adjunctive treatment | ||||
RAAS blockade | 33 (84.6) | 9 (81.8) | 15 (93.8) | 0.596 |
Statins | 21 (53.8) | 5 (45.5) | 10 (62.5) | 0.676 |
Avg, average; CNI, calcineurin inhibitor; RAAS, renin−angiotensin−aldosterone system.